Introduction

6
contribution of a disease was considered if at least two independent case-control 144 collections from the same disease were grouped with consistent effects.
145
Novelty of the variants: Our independent SNP associations were classified into "known" Table S1 and Figure S1 , respectively.
175
The global meta-analysis revealed 42 non-hla significantly associated loci. Figure S2 ). Sixteen variants were meta-analyzed under a fixed effects model, whereas 178 eleven with random effects based on study heterogeneity.
179
To comprehensively explore the combinations of diseases contributing to the 180 associations we applied a subset-based meta-analysis implemented in ASSET. [ e Disease contributing to the association observed by the subset meta-analysis method with ASSET. 25 The diseases for which this locus has never been reported before at genomewide significance level are shown in boldface. *Denotes novel loci in the study. Chr: chromosome; OR: odds ratio; CI: confidence interval; IIM: idiopathic inflammatory myopathy; RA: rheumatoid arthritis; SLE: systemic lupus erythematosus; SSc: systemic sclerosis.
All the variants in the table were imputed in at least one of the 18 case-control collections.
To assess whether the associated variants lie in coding and non-coding Table S3 ). (Table 3) , as suggested by Capture HiC (C-HiC) data (Table S5 ). These 244 independent evidences propose a mechanistic approach to understand the modulation of SSc and RA (Table 4) . Imatinib is currently being tested for SSc (NCT00555581) and
329
RA (NCT00154336). 
--a Based on our meta-analysis, diseases contributing to the observed association. The diseases where the association of this variant has never been reported before at genome-wide significance level are shown in boldface. was also a meta-analysis of GWAS data-was focused on pediatric autoimmune 342 diseases, whereas our study was on a new combination of diseases in adult population.
343
In summary, this is the first study to investigate shared common genetic from the meta-analysis. In panels where significant variants remained after 597 conditioning, there are several independent variants in the region. In panels E, P, and Y 598 the remaining independent variants were not significant in the meta-analysis. 
